News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
127,805 Results
Type
Article (5179)
Company Profile (31)
Press Release (122595)
Section
Business (42645)
Career Advice (132)
Deals (7453)
Drug Delivery (10)
Drug Development (15399)
Employer Resources (15)
FDA (2721)
Job Trends (3044)
News (66836)
Policy (4872)
Tag
Academia (309)
Adcomms (2)
Allergies (10)
Alliances (5524)
ALS (11)
Alzheimer's disease (200)
Antibody-drug conjugate (ADC) (38)
Approvals (2764)
Artificial intelligence (28)
Autoimmune disease (4)
Automation (3)
Bankruptcy (44)
Best Places to Work (2757)
Biosimilars (14)
Biotechnology (18)
Bladder cancer (27)
Brain cancer (5)
Breast cancer (59)
Cancer (527)
Cardiovascular disease (38)
Career advice (116)
Career pathing (2)
CAR-T (23)
Cell therapy (67)
Cervical cancer (6)
Clinical research (13281)
Collaboration (109)
Compensation (39)
Complete response letters (2)
COVID-19 (493)
CRISPR (6)
C-suite (14)
Cystic fibrosis (24)
Data (647)
Depression (10)
Diabetes (42)
Diagnostics (1241)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (15)
Drug pricing (8)
Drug shortages (5)
Duchenne muscular dystrophy (29)
Earnings (32945)
Editorial (6)
Employer branding (3)
Employer resources (12)
Events (22718)
Executive appointments (57)
FDA (3053)
Frontotemporal dementia (2)
Funding (95)
Gene editing (12)
Generative AI (3)
Gene therapy (52)
GLP-1 (103)
Government (587)
Grass and pollen (1)
Guidances (102)
Healthcare (3849)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (25)
Indications (6)
Infectious disease (521)
Inflammatory bowel disease (25)
Influenza (9)
Intellectual property (12)
Interviews (22)
IPO (4694)
IRA (1)
Job creations (431)
Job search strategy (101)
Kidney cancer (1)
Labor market (5)
Layoffs (50)
Legal (705)
Liver cancer (18)
Lung cancer (86)
Lymphoma (44)
Machine learning (1)
Management (5)
Manufacturing (45)
MASH (21)
Medical device (2879)
Medtech (2880)
Mergers & acquisitions (2864)
Metabolic disorders (115)
Multiple sclerosis (20)
NASH (5)
Neurodegenerative disease (10)
Neuropsychiatric disorders (6)
Neuroscience (278)
NextGen: Class of 2025 (1044)
Non-profit (665)
Now hiring (1)
Obesity (52)
Opinion (21)
Ovarian cancer (18)
Pain (14)
Pancreatic cancer (22)
Parkinson's disease (21)
Partnered (3)
Patents (28)
Patient recruitment (18)
Peanut (3)
People (4283)
Pharmaceutical (11)
Pharmacy benefit managers (5)
Phase I (3380)
Phase II (5551)
Phase III (5331)
Pipeline (627)
Policy (13)
Postmarket research (623)
Preclinical (1161)
Press Release (17)
Prostate cancer (12)
Radiopharmaceuticals (44)
Rare diseases (65)
Real estate (676)
Recruiting (8)
Regulatory (3956)
Reports (8)
Research institute (295)
Resumes & cover letters (13)
Rett syndrome (3)
RSV (11)
Schizophrenia (10)
Series A (20)
Series B (10)
Sickle cell disease (4)
Special edition (1)
Spinal muscular atrophy (47)
Sponsored (3)
Startups (334)
Stomach cancer (2)
Supply chain (14)
Tariffs (10)
The Weekly (4)
Vaccines (140)
Venture capitalists (7)
Weight loss (18)
Women's health (1)
Date
Today (65)
Last 7 days (341)
Last 30 days (872)
Last 365 days (7853)
2025 (2888)
2024 (8346)
2023 (9387)
2022 (12147)
2021 (14120)
2020 (12623)
2019 (8297)
2018 (6397)
2017 (5673)
2016 (4920)
2015 (6331)
2014 (4075)
2013 (2930)
2012 (3341)
2011 (3740)
2010 (3290)
Location
Africa (108)
Alabama (11)
Arizona (43)
Arkansas (4)
Asia (6959)
Australia (960)
California (1391)
Canada (583)
China (137)
Colorado (93)
Connecticut (66)
Delaware (42)
Europe (15998)
Florida (229)
Georgia (46)
Idaho (6)
Illinois (103)
Indiana (127)
Japan (46)
Kansas (35)
Kentucky (4)
Louisiana (4)
Maine (36)
Maryland (157)
Massachusetts (1147)
Michigan (45)
Minnesota (66)
Missouri (15)
Montana (5)
Nebraska (3)
Nevada (10)
New Hampshire (14)
New Jersey (634)
New Mexico (5)
New York (395)
North Carolina (241)
Northern California (657)
Ohio (34)
Oregon (3)
Pennsylvania (340)
Puerto Rico (1)
Rhode Island (3)
South America (159)
South Carolina (2)
Southern California (514)
Tennessee (10)
Texas (228)
United States (5666)
Utah (32)
Virginia (12)
Washington D.C. (9)
Washington State (156)
West Virginia (1)
Wisconsin (6)
127,805 Results for "90".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aurora Pharmaceutical Awards $90,000 in Scholarships to 28 Veterinary Students Across the Nation
May 2, 2025
·
2 min read
Press Releases
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab
May 5, 2025
·
8 min read
Layoffs
Cargo Lays Off 90% of Staff and Stops Development Work
The biotech is exploring opportunities for a reverse merger or other business combinations. CFO and now interim CEO Anup Radhakrishnan will take charge of these negotiations.
March 19, 2025
·
2 min read
·
Tristan Manalac
Press Releases
HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials
April 29, 2025
·
6 min read
Press Releases
New Harris Poll findings reveal HAE patients are unsatisfied with current prophylactic treatment options, with over 90% interested in trying new therapies
April 29, 2025
·
5 min read
Press Releases
Attovia Therapeutics Announces $90 Million Series C Financing to Advance ATTOBODY-based Programs through Clinical Proof of Concept
April 16, 2025
·
3 min read
Press Releases
Beyonttra™ (acoramidis), the First Near-complete TTR Stabilizer (≥90%), Approved in Japan to Treat ATTR-CM
March 28, 2025
·
7 min read
Press Releases
BEYONTTRA® (acoramidis), the First Near-complete TTR Stabilizer (≥90%), Approved by the UK Medicines and Healthcare Products Regulatory Agency to Treat ATTR-CM
April 28, 2025
·
10 min read
Immunology and Inflammation
I&I Startup Bambusa Nabs $90M for Bispecific Antibodies
The company, helmed by BioNTech alums, is developing therapies aimed at dermatological, respiratory and gut-related indications.
February 14, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Biotechnology Market Size Expected to Reach USD 5.90 Trillion by 2034
February 18, 2025
·
1 min read
1 of 12,781
Next
